Metrics as of 10/16/2026, 03:08 PM (Berlin time), refresh in progress.
Curaleaf Holdings Stock
Curaleaf Holdings, Inc.
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United States
- CEO
- Boris Alexis Jordan
- Employees
- 5,554
- Market cap
- $2.8 B
- IPO
- 07/04/2021
Curaleaf Holdings, Inc. operates as a prominent company within the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry. Founded in 2010, the company is headquartered in Stamford. Its business activities are conducted through both domestic and international operating segments. The…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Curaleaf Holdings stock: price history
1D
-2.4%
1W
-11.9%
1M
-15.4%
6M
+10.4%
YTD
+16.2%
1Y
-14.6%
2Y
-4.0%
5Y
-69.7%
10Y
–
Next earnings date
Next earnings date
03/11/2026 (in 17 days)
Volatility around earnings
~33% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 16/10/26. Not a buy or sell signal.Beta
What does this mean?
Double top
BearishThe price failed at a similar high twice, with a pullback in between. This M-shaped pattern is a classic reversal signal from an uptrend into a downtrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about Curaleaf Holdings
Analyst assessment of Curaleaf Holdings
0
STRONG BUY
5
BUY
2
HOLD
0
SELL
0
STRONG SELL
7
TOTAL · Buy
As of: 08/08/2024
Curaleaf Holdings stock metrics
P/E
-61.22
P/B
2.55
EV/EBITDA
15.4
RETURN ON EQUITY
1.4%
NET MARGIN
3.7%
DEBT/EQUITY
1.05
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
72.6%
FLOAT SHARES
169,541,605
AVG. DAILY VOLUME (30D)
512,156
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Curaleaf Holdings stock
What does Curaleaf Holdings do?
Curaleaf Holdings, Inc. is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in United States.
The CEO is Boris Alexis Jordan, the company employs around 5,554 people.
The IPO was on 07/04/2021; the stock trades on TSX under the ticker CURA.TO.
What do analysts say about Curaleaf Holdings stock?
7 analysts rate the stock, the consensus is Buy (as of 08/08/2024).
This is an external assessment, not a statement by Market Jury.
When does Curaleaf Holdings report next?
The next earnings date is 03/11/2026.
Around past earnings, price swings were roughly 33% stronger than usual.
Does Curaleaf Holdings pay a dividend?
No, Curaleaf Holdings currently does not pay a dividend.
Which stocks are comparable to Curaleaf Holdings?
Comparable stocks include Zoetis, Viatris, Lantheus Holdings, Amneal Pharmaceuticals, Indivior Pharmaceuticals, Eton Pharmaceuticals, Pacira BioSciences and Amphastar Pharmaceuticals.
How can I get Curaleaf Holdings stock analyzed?
Clicking "Analyze stock" lets five strategies assess Curaleaf Holdings against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.